Our review Nintendo Switch 2 console has arrived a day ahead of the full launch of Nintendo’s new generation of console, and we’ve put together a quick unboxing video. In this video, the Switch 2 ...

Microbot Medical ( (MBOT)) has issued an announcement. On November 5, 2025, Microbot Medical announced the limited commercial availability of its LIBERTY® Endovascular Robotic System in the U.S. This ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

Ultra-thin design turns heads, but practical questions remain. Watch our review video Dubai: Apple's boldest iPhone experiment in years arrives in UAE stores September 19, and the iPhone Air is ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

JBL has revamped its signature Flip 7 and Charge 6 portable speakers line with new and improved features. The new generation of speakers not only arrives in a range of bold colorways but also features ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

We finally have a Nintendo Switch 2, and it's time to take it out of its box! Not only do we do a Nintendo Switch 2 unboxing, but we also open up and check out the Nintendo Switch 2 Pro Controller, ...

We recently published a list of the 10 Best Rising Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where Microbot Medical Inc. (NASDAQ:MBOT) stands against ...

New York City – In a bustling event on 5th Avenue that drew over 100 journalists, content creators, and industry insiders, Nintendo made waves by unveiling the much-anticipated Switch 2. The console ...

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...